The inventor and owner of the patents – Dr. Horst P. O. Wolf quits with ALTANA Pharma AG, Constance and proceeds with the development.
1998
Filing of new oxirane carbonylic acids (Etomoxir-backups) for patent (diabetes indication).
1999 - 2003
Out-licensing to MediGene AG (Germany). The pase II clinical trial was stopped due to accidential side effects (increase of liver enzymes in few cases). Late statistical evaluation has shown no differences between the verum and the placebo groups. The BioScience-Beteiligungs-Anstalt (LI) has been in-licensed the patents.
2007 - 2011
MetrioPharm AG (Switzerland) keeps a license going. This agreement has been quitted by us in 2011.
2013 -
Dr. Wolf - Bioscience has been proceeding the business on success of the BioScience-Beteiligungs-Anstalt (LI).
Lieber User, zur Service - Optimierung benutzt diese Website Cookies. Mit der Nutzung der Website stimmen Sie bitte der Verwendung zu.
Dear User, this site is using cookies in order to improve our services. Find out more on how we use cookies and how you can change your settings.
